CAGE Bio begins double-blind placebo-controlled clinical trial of topical DNA Aptamer therapy CGB-600 for vitiligo treatment: San Carlos, California Saturday, October 25, 2025, 12 ...

The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help ...

Incyte's growth potential and low valuation are driven by a strong pipeline and strategic focus. Read here for an investment analysis of INCY stock.

Incyte INCY has put up a stellar performance year to date on the back of better-than-expected quarterly results, and positive ...

Apart from medicines, another common treatment for vitiligo is phototherapy. This method uses targeted ultraviolet (UV) light ...

An expert discusses how the lack of transparency in medication pricing creates a "black box" between actual drug costs and ...

In a single-center retrospective observational study at the Bari Polyclinic, researchers analyzed 50 adults with non-segmental vitiligo affecting 0.5 to 10% of their body surface area, including the ...

Under the Gaza ceasefire deal, Israel has agreed to hand over the bodies of 15 Palestinians in return for every dead Israeli ...

CNW/ - Incyte Biosciences Canada today announced that Health Canada has approved Opzelura® (ruxolitinib (as ruxolitinib ...